Leverage, Where is Thy Sting

Leverage, Where is Thy Sting

Coronavirus is changing the world. Right now, Italy is in shut down, and Europe is heading that way. In the U.S., the states, organizations, and companies are leading and closing schools and universities, canceling or deferring events, and implementing work from home policies. What will the impact be?

Who knows. I believe that the current reported number of cases of 2,174 in the U.S. is far below the actual number as testing has failed. Until testing gets on track and we can see where the virus is, then only can we manage it. As those in business know, Measure What Matters, and if you can’t measure it, you can’t fix it.

Again, I expect that parts of the U.S. or all of it will end up with some form of Italian solution to the virus. If you are not sure what that looks like, I will refer you to Italy’s Nightmare Offers a Chilling Preview of What’s Coming. The effect of that will be devastating for many companies and individuals in the U.S. as revenues and income plummet.

However, once more, the financial industry’s offer of a helping noose will exacerbate the problem. Private Equity has acquired an enormous number of companies in the U.S. over the last two decades. To get the returns that their investors are looking for, they leverage the businesses, often with negative results. Today, however, I expect that the damage to these companies from a slowing economy will put many in breach of their loan covenants. Thus it could lead to a dramatic increase in bankruptcies across the country. These bankruptcies will be a negative feedback loop on an already suffering economy and one that the country will be hard-pressed to handle. Thus I would expect the bail-out requests already forming.

Last year, larger non-finance corporations had a record of $13.5 trillion of outstanding debt, according to an OECD report. A growing portion of that is in the form of riskier bonds, and experts worry an economic crisis spurred by coronavirus could send corporations on cost-cutting sprees or to default. Since the financial crisis, corporations loaded up on debt. According to a Morgan Stanley analyst, currently, estimated one-in-six U.S. companies don’t have the cash flow to cover interest payments. In the last decade, about one-fifth of new bonds issued were below investment-grade.

Investors are shedding riskier assets as they realize the impact of the coronavirus. Energy companies have about $88 billion in bonds due this year, and analysts expect defaults to surpass 2016 levels. Rating agencies are watching particularly vulnerable industries like auto, airlines, and hospitality. S&P put Nashville’s Ryman Hospitality Properties on a credit rating watch after massive cancellations threatened to whack revenue by $40 million.

The Administration’s 2017 tax cuts helped many U.S. companies improve their cash positions; however, companies wasted this largess on the typical “Sugar Highs” of companies – share buyback and increased distributions to private Equity. The result of this is that most of these companies are in no better shape to handle a server downturn than they were before.

As Hemingway said, “How did you go bankrupt?” “Two ways. Gradually, then suddenly.”

Leverage is lovely until it isn’t. The fall out from this will be bigger than expected.

 

Copyright (c) 2020, Marc A. Borrelli

Healthcare is too Important to be left to the Market!

Healthcare is too Important to be left to the Market!

The U.S. prides itself on being a “capitalistic/market based” country; however, as we see with the coronavirus, healthcare is too important for the market to determine its practices.

In the U.S., hospitals moved to market efficiencies with lean operations and effectively just in time processes after 1983, when Congress transformed how Medicare reimbursed hospitals. The United States had approximately nine hospital beds for every 1,000 people by the late 1950s., and between 1945 and 1983, about 75% of those beds were in use. As health costs became an increasing concern, the Congressional action was aimed at increasing efficiency at hospitals to reduce Medicare costs. The change in reimbursement forced hospitals to cut capacity and costs, lead to the rise of managed care, and the delivery of health care out of hospitals and into doctors’ offices. Before the Congressional action, many of these beds went unused in regular times but were available during periods of extreme stress. When the flu epidemic swept the country during the winter of 1957 and 1958, which was the worst outbreak since the famous pandemic of 1918, hospitals absorbed the surge without any problems. Even New York City, which was one of the hardest hit, its hospitals coped with the increased demand by adding a few extra beds.

Today, hospitals lean and just in time processes have made them very efficient, but unprepared to handle a sudden influx of seriously ill patients as we expect from Covid-19. As hospitals sought increased efficiency, they consolidated to drive down costs further. To protect themselves from the competition, they persuaded many state governments to introduce “certificate of need” laws or CON laws that artificially limit the supply of medical equipment. These laws create shortages of medical equipment that could prove disastrous during a pandemic. Today as hospitals seek to prepare for a potential onslaught of patients from Covid-19, the CON laws will limit their ability to do so.

We see with manufacturing, lean and just in time is excellent improving efficiencies and profits; but where there is a significant supply-side disruption as are experiencing with coronavirus, it is disastrous. We are seeing the same things happen with healthcare.

Another issue with the market in healthcare is the acquisition of existing drugs by companies that then increase the prices dramatically. A recent study noted. “In recent years, the prices of old, off-patent therapeutics with limited competition have become the target of a profit-boosting tactic among pharmaceutical companies: acquiring potentially underpriced drugs and subsequently increasing the prices. Strong candidates for this practice include therapeutics with few, or no, bioequivalent alternatives serving niche markets. Despite having long lost patent protection and exclusivity, many of these medications treat smaller populations and thus promise insufficient profits to potential generic competitors.” Since these drugs are already developed the standard refrain of drug companies that they need high prices to support drug development doesn’t hold water.

I know several people who have told me how private equity is the cure, but an industry looking for an annual return of 35% and doesn’t care about what it delivers is something we cannot afford.

In the U.S., 530,000 families turn to bankruptcy each year due to medical bills they can’t pay. For the wealthiest country in the world, this is a resounding failure. Sixty-six percent of personal bankruptcies between 2013 to 2016 resulted from medical issues. People could not pay their medical bills, either they were too expensive initially, or they had to take time off of work and were not getting paid. The research also noted that medical bills explicitly caused 58.5 percent of bankruptcies, while 44.3 percent were caused in part by income loss due to illness.

These numbers are getting the attention of Congress, and even in the partisan world, lawmakers on both sides are seeking to get rid of surprise medical bills. However, two of private equity’s biggest names have spent millions to make sure that any attempts to fix the U.S. healthcare system don’t interfere too much with their future profits, thus impeding such efforts.

Surprise medical bills occur when out-of-network providers at hospitals in their insurance networks treat patients. Surprise medical bills are getting more frequent, and 20% of patients who have elective surgery receive surprise medical bills. Other reasons are that while the average price of a visit to the emergency room increased 176% between 2008 and 2017, insurance companies have narrowed the number of doctors that are in-network, hoping to mostly find the doctors and hospitals that charge them the lowest amount.

However, using these doctors result in patients getting hit with surprise out-of-network costs from consulting physicians, especially in emergencies (such as being quarantined for coronavirus).

Private equity has played a significant role in driving up costs. The biggest P.E. firms have acquired private physician networks that have played a role in raising patient costs. In 2016, Blackstone paid $6.1 billion for TeamHealth, a hospital staffing company. In 2018, KKR acquired EmCare, a provider of emergency-care staffing services, as part of a $9.9 billion take-private buyout of Envision Healthcare. In 2017, Welsh, Carson Anderson & Stowe, TPG Capital, and Humana acquired Kindred Healthcare for around $4.1 billion.

Physician staffing companies are an attractive investment for private equity firms. With little regulation of billing practices, PE-backed clinics and their doctors can charge whatever they like, and patients often aren’t in a position to object. The system leaves insurance companies and patients arguing over bills. TeamHealth has drawn condemnation for aggressively pursuing unpaid medical bills while under Blackstone’s ownership. In the face of pressure from the media, the company ultimately pledged to stop suing those who couldn’t pay and reiterated it was against surprise billing.

One of the reasons for the increase in fees is that private equity has leveraged these companies when acquiring them. Now saddled with debt, increased pricing is their only salvation. According to Dr. Eileen Appelbaum, a co-director at the Center for Economic and Policy Research  TeamHealth owes $2.7 billion due by 2024, and Envision owes $5.4 billion due the next year.  “They each have a tremendous amount of debt,” Appelbaum said. “That’s their business model.”

“Unless you’re Bill Gates, you’re just one serious illness away from bankruptcy,” according to Dr. David U. Himmelstein of the Physicians for a National Health Program (PNHP) said in a press release. “For middle-class Americans, health insurance offers little protection. Most of us have policies with so many loopholes, co-payments, and deductibles that illness can put you in the poorhouse,”

The middle class’s downfall is more likely due to bankruptcy from medical bills than for the lower classes. Middle-class Americans are experiencing increasing co-payments and deductibles. The ACA helped the poor and, as they have few assets, generally do not go through bankruptcy proceedings.

With the coronavirus, there will be pressure on these companies to absorb more costs, which might lead them to breach their loan covenants. In other industries, this could lead to bankruptcy, which Private Equity is known for; however, as medical systems are so important, they will undoubtedly be bailed out by the taxpayer. Once more protecting the returns to private equity and leaving the rest of us with the bill. As I have said before, “The U.S. is capitalism for the poor, and socialism for the rich.”

The U.S. Healthcare industry is ill-equipped to deal with a public health crisis like coronavirus as a result of its efficiencies and debt loads. Depending on the human toll resulting from Covid-19 I expect the U.S. healthcare industry to look very different in ten years. The question is, will it be a third world model with the best resources only for the rich or a model reflective of the wealthiest country in the world?

 

Copyright (c) 2020, Marc A. Borrelli

Recent Posts

The Downfall of Boeing: A Lesson in Core Values

The Downfall of Boeing: A Lesson in Core Values

Boeing’s 737 Max issues highlighted the company’s sacrifice of safety for financial performance, resulting in a tarnished reputation. The prioritization of profit over core values also damaged the FAA’s credibility and revealed a lack of accountability for top executives. This downfall serves as a reminder of the importance of maintaining core values and prioritizing them over short-term financial gains.

Resolutions, Here We Go Again.

Resolutions, Here We Go Again.

In reflecting on 2021 resolutions, the author scored themselves in three categories and sought to improve success in 2022 by addressing friction points. Drawing on advice from social psychologist Wendy Wood, the author identified areas to reduce or increase friction in their failed resolutions. By making these adjustments, the author aims to enhance their goal achievement and encourages others to consider friction when setting resolutions.

Understanding and Optimizing Your Cash Conversion Cycle

Understanding and Optimizing Your Cash Conversion Cycle

Understanding and optimizing the Cash Conversion Cycle is crucial for business growth, as it impacts cash flow and the ability to access external capital. This cycle consists of four components: Sales, Make/Production & Inventory, Delivery, and Billing and Payments. To improve the Cash Conversion Cycle, companies can eliminate mistakes, shorten cycle times, and revamp their business models.

Discovering Your Niche: Why You Need to Be Famous for Something

Discovering Your Niche: Why You Need to Be Famous for Something

As an entrepreneur, it’s crucial to specialize in a specific area and become famous for something, allowing you to generate referrals and build your brand. Understanding the “job” you’re hired for helps you stand out in the marketplace and communicate your value proposition effectively. By providing value to your clients, you can adopt a value-based pricing approach, ensuring your business remains competitive and maintains a strong market presence.

Rethinking Your Pricing Model: Maximizing Margins and Providing Value

Rethinking Your Pricing Model: Maximizing Margins and Providing Value

Rethink your pricing model by focusing on the value you provide and your customers’ Best Alternative To a Negotiated Agreement (BATNA). This approach can help you maximize margins while delivering better value to your clients. Assess your offerings and brainstorm with your team to identify pricing adjustment opportunities or eliminate commodity products or services.

Do you know your Profit per X to drive dramatic growth?

Do you know your Profit per X to drive dramatic growth?

I recently facilitated a workshop with several CEOs where we worked on the dramatic business growth model components. One of the questions that I had asked them beforehand was, "What is Your Profit/X?" The results showed that there this concept is not clear to many....

The War for Talent: 5 Ways to Attract the Best Employees

The War for Talent: 5 Ways to Attract the Best Employees

In today’s War for Talent, attracting the best employees requires a focus on value creation, core customer, brand promise, and value delivery. Clearly articulate your company’s mission, identify your “core employee” based on shared values, and offer more than just a salary to stand out as an employer. Utilize employee satisfaction metrics and showcase your company’s commitment to its workforce on your website to make a strong impression on potential candidates.

Are you killing your firm’s WFH productivity?

Are you killing your firm’s WFH productivity?

Productivity remained during WFH with COVID. However, further analysis found that hourly productivity fell and was compensated for by employees working more hours. What was the culprit – Meetings. Want to increase productivity, have fewer meetings.